1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program

BACKGROUND: Trimethoprim sulfamethoxazole (TMP-SMX) is the preferred agent for Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised hosts (ICH). However, TMP-SMX is frequently avoided due to an adverse drug reaction (ADR) history. We report on a novel multicentre programmatic approach t...

Descripción completa

Detalles Bibliográficos
Autores principales: Smibert, Olivia, Urbancic, Karen, Douglas, Abby, Devchand, Misha, Slavin, Monica, Trubiano, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252477/
http://dx.doi.org/10.1093/ofid/ofy210.1406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252477/
http://dx.doi.org/10.1093/ofid/ofy210.1406

Ejemplares similares